10 Unforgivable Sins Of Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably protected for use - and failure to do so may possibly be grounds for compensation. Our lawyers are functioning tough to acquire those hurt by the drug the compensation they're entitled to.
While bleeding is a frequent complication associated with anticoagulants, it has been alleged that Xarelto is far more harmful than traditional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This signifies that, within the event of an emergency, sufferers might be at risk for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.
If you or a loved one suffered a serious bleeding occasion following taking Xarelto, you might have legal recourse. For more details, make contact with us these days to possess your case reviewed, totally free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future healthcare bills, lost wages, discomfort and suffering and, in cases of death, funeral expenditures. In addition, they're in search of punitive damages, which are typically awarded to punish the defendant and deter other firms from check acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding inside the occasion of an emergency. Plaintiffs within the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
